Description
An inhibitor of topoisomerase I that inhibits topoisomerase I-mediated DNA cleavage 10-fold more potently than topotecan; inhibits the growth of and is cytotoxic to human and mouse bone marrow cells in vitro (IC50s = 0.4 and 2.3 nM, respectively; IC90s = 1.2 and 8.4 nM, respectively); inhibits the growth of and is cytotoxic to human tumor cell lines in vitro (IC50s = 0.15-2 nM; IC90s = 0.7-8.3 nM); inhibits tumor growth in mouse xenograft models (1.36-2.7 mg/kg)
Formal name: 2,3-dimethoxy-12-[2-(methylamino)ethyl]-benzo[c][1,3]benzodioxolo[5,6-h][1,6]naphthyridin-13(12H)-one
Synonyms:
Molecular weight: 407.4
CAS: 529488-28-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Topoisomerases||Research Area|Cancer|Cell Death||Research Area|Cancer|DNA Damage and Repair|Topoisomerase